T-Cell Research
Used to study thymic-dependent T-lymphocyte maturation and immune reconstitution in immunosuppressed animal models.
Garaci et al. 2007
Immune Response Studies
Free Shipping on orders over $200
Scan the QR code on any vial to verify its batch, COA, and origin in seconds. Secure traceability from our lab to your bench.
Thymosin Alpha-1 is a natural thymic peptide and one of the most studied immune modulators — researched for strengthening and rebalancing the immune system's response to infection, inflammation, and disease.
28-amino-acid thymic peptide
The pathways Thymosin Alpha-1 acts on — and what each one does. The animation traces its signal outward from the compound to every target it engages.
Thymosin Alpha-1 promotes the maturation and differentiation of T-lymphocytes and modulates the balance of T-cell subsets in preclinical immunology models.
Research indicates Tα1 signals through Toll-like receptors (notably TLR2 and TLR9) on dendritic cells and monocytes, influencing innate-immune activation and cytokine expression.
In-vitro and animal studies report enhanced natural-killer-cell activity and a shift toward a Th1 cytokine profile (IFN-γ, IL-2), supporting antiviral and antitumour immune-response research.
The main areas Thymosin Alpha-1 is being studied for — and the study-reported figures behind them.
Used to study thymic-dependent T-lymphocyte maturation and immune reconstitution in immunosuppressed animal models.
Garaci et al. 2007Investigated in hepatitis and other viral models for its influence on innate and adaptive antiviral immunity.
Loggi et al. 2020Studied as an immune adjuvant in preclinical tumour models for enhancement of NK and cytotoxic T-cell responses.
Costantini et al. 2019Examined for modulation of inflammatory cytokine networks and dendritic-cell function in vitro.
Romani et al. 2012An interactive 3D model rendered from the compound record — rotate and explore its structure.
C129H215N33O55
Every batch of Thymosin Alpha-1 is sent to an accredited independent laboratory before it ships. Here is what we screen for.
| Strength | 10mg |
| Molecular Formula | C129H215N33O55 |
| Molecular Weight | 3108.29 g/mol |
| Purity | >99% (HPLC) |
| Form | Lyophilized Powder |
| Verified Purity | >99% |
| Quantity | 10mg |
| Appearance | White to off-white powder |
| Stability | 24 months from manufacture date when stored properly |
| Lyophilized Storage | Store at -20°C, protected from light |
| Reconstituted Storage | Store at 2-8°C, use within 30 days |
Thymosin Alpha-1 (Tα1) is an acetylated 28-amino-acid peptide originally isolated from thymic tissue (thymosin fraction 5). It is a well-characterized immunomodulator studied for its effects on T-cell maturation, Toll-like-receptor signaling, and innate/adaptive immune balance in cell-culture and animal models.
No. Thymosin Alpha-1 is not approved by the FDA for any use in the United States. A synthetic form (thymalfasin) is approved as an immunomodulator in a number of other countries, but this product is supplied strictly as a reference compound for in-vitro laboratory research.
Store the lyophilized powder at −20°C, protected from light; it is stable for approximately 24 months from manufacture. After reconstitution, keep refrigerated at 2–8°C and use within 30 days. This is storage guidance for the researcher, not a shipping requirement.
Each lot is ≥99% pure by HPLC with identity confirmed by mass spectrometry and ships with third-party analytical documentation of purity, net peptide content, and endotoxin screening.
Independent published research indexed from PubMed and peer-reviewed journals — not Eon Peptides claims.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.